SCHEMBL317158

SCHEMBL317158

CC(C)(C)OOC(=O)C1CCC(C(=O)OOC(C)(C)C)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.36
TDP1 Q9NUW8 3/20 0.36
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
HRH3 Q9Y5N1 1/20 0.34
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32
ADRB3 P13945 1/20 0.32
HTT P42858 2/20 0.31
POLB P06746 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
TP53 P04637 1/20 0.31
THRA P10827 1/20 0.31
THRB P10828 1/20 0.31
KMT2A Q03164 2/20 0.30
MEN1 O00255 1/20 0.30
MAPT P10636 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL383633 1.00 TSHR (0.36) TSHRTDP1ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL28854293 0.92 LMNA (0.37) TSHRTDP1ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL382048 0.91 SMN1; SMN2 (0.41) TSHRTDP1ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL382706 0.91 ADRB2 (0.40) TSHRTDP1ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL382062 0.89 CES2 (0.41) TSHRTDP1ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL22775616 0.89 CES2 (0.41) TSHRTDP1ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL194560 0.86 ALDH1A1 (0.34) TSHRTDP1ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL3635120 0.80 LMNA (0.35) TSHRTDP1ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL2197391 0.79 KMT2A (0.40) TDP1SMN1; SMN2HTTRAB9ATP53
SCHEMBL29120025 0.79 ADRB2 (0.41) TSHRTDP1ALDH1A1HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 322 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118974149-A Open cell polymer foam composition with adjustable tortuosity and preparation method thereof 布拉斯科有限公司 2024-11-15 CN claimed
EP-0575891-B1 Toner for developing electrostatic image and image forming method CANON KK (JP) 1997-10-29 EP claimed
US-5447813-A Styrene binder resin, magnetic material CANON KABUSHIKI KAISHA (JP) 1995-09-05 US claimed
EP-0575891-A2 Toner for developing electrostatic image and image forming method CANON KABUSHIKI KAISHA (JP) 1993-12-29 EP claimed
JP-57164106-A None JP disclosed
JP-56167706-A None JP disclosed
US-6413691-B1 None US disclosed
CN-122095147-A Leather treatment agent for imparting water and oil repellency comprising a silicone- (meth) acrylate copolymer and an organic binder 2026-05-26 CN disclosed
CN-122070393-A Textile treatment using amorphous silicone- (meth) acrylate copolymers, crystalline (meth) acrylate-based (co) polymers and blocked isocyanates 美国陶氏有机硅公司 2026-05-19 CN disclosed
CN-122029320-A Textile treatments for imparting oil repellency include the use of non-crystalline silicone- (meth) acrylate copolymers, crystalline polymers, and blocked isocyanates 陶氏环球技术有限责任公司 2026-05-12 CN disclosed
EP-3947611-B1 A MIDDLE-PRESSURE POLYMERIZATION PROCESS FOR LIQUID ETHYLENE COPOLYMERS BASF SE (DE) 2026-05-06 EP disclosed
US-20250381127-A1 COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A SILICONE POLYMER OREAL (FR) 2025-12-18 US disclosed
EP-0382320-B1 Process for preparation of stable interpenetrating polymer blends, comprising a poly(vinyl aromatic) polymer phase and a poly(alkylene) phase SHELL INT RESEARCH (NL) 1994-09-07 EP disclosed
EP-0575891-A2 Toner for developing electrostatic image and image forming method CANON KABUSHIKI KAISHA (JP) 1993-12-29 EP disclosed
EP-0531990-A1 Toner for developing electrostatic image and heat-fixing method CANON KABUSHIKI KAISHA (JP) 1993-03-17 EP disclosed
EP-0519715-A1 Magnetic toner and process for producing magnetic toner CANON KABUSHIKI KAISHA (JP) 1992-12-23 EP disclosed
US-5084513-A PROCESS FOR PREPARATION OF STABLE INTERPENETRATING POLYMER BLENDS, COMPRISING A POLY(VINYL AROMATIC) POLYMER PHASE AND A POLY(ALKYLENE) PHASE SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 1992-01-28 US disclosed
EP-0382320-A2 Process for preparation of stable interpenetrating polymer blends, comprising a poly(vinyl aromatic) polymer phase and a poly(alkylene) phase SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1990-08-16 EP disclosed
JP-S57164106-A PRODUCTION OF IMPACT-RESISTANT STYRENE RESIN DENKI KAGAKU KOGYO KK 1982-10-08 JP disclosed
JP-S56167706-A POLYMERIZATION OF STYRENE TYPE MONOMER DENKI KAGAKU KOGYO KK 1981-12-23 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250381127-A1 COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A SILICONE POLYMER H1-0, PARN, FASN TSHR 1030/4885TDP1 1990/4885ALDH1A1 2361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.